Ay C - Search Results

1

Clinical implications of incidental venous thromboembolism in cancer patients.

Mulder FI, Di Nisio M, Ay C, Carrier M, Bosch FTM, Segers A, Kraaijpoel N, Grosso MA, Zhang G, Verhamme P, Wang TF, Weitz JI, Middeldorp S, Raskob G, Beenen LFM, Büller HR, van Es N. Mulder FI, et al. Among authors: ay c. Eur Respir J. 2020 Feb 6;55(2):1901697. doi: 10.1183/13993003.01697-2019. Print 2020 Feb. Eur Respir J. 2020. PMID: 31727694 Free article. Clinical Trial.

2

Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.

Vormittag R, Bencur P, Ay C, Tengler T, Vukovich T, Quehenberger P, Mannhalter C, Pabinger I. Vormittag R, et al. Among authors: ay c. J Thromb Haemost. 2007 Mar;5(3):497-502. doi: 10.1111/j.1538-7836.2007.02337.x. Epub 2006 Nov 28. J Thromb Haemost. 2007. PMID: 17155964 Free article.

3

Venous thromboembolism--a manifestation of the metabolic syndrome.

Ay C, Tengler T, Vormittag R, Simanek R, Dorda W, Vukovich T, Pabinger I. Ay C, et al. Haematologica. 2007 Mar;92(3):374-80. doi: 10.3324/haematol.10828. Haematologica. 2007. PMID: 17339187 Free article.

4

High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.

Ay C, Jungbauer LV, Sailer T, Tengler T, Koder S, Kaider A, Panzer S, Quehenberger P, Pabinger I, Mannhalter C. Ay C, et al. Clin Chem. 2007 Jul;53(7):1235-43. doi: 10.1373/clinchem.2006.085068. Epub 2007 May 17. Clin Chem. 2007. PMID: 17510305

5

The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.

Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I. Ay C, et al. Thromb Haemost. 2007 Oct;98(4):777-82. Thromb Haemost. 2007. PMID: 17938801

6

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, Koder S, Kornek G, Marosi C, Wagner O, Zielinski C, Pabinger I. Ay C, et al. Blood. 2008 Oct 1;112(7):2703-8. doi: 10.1182/blood-2008-02-142422. Epub 2008 Jun 6. Blood. 2008. PMID: 18539899 Free article.

7

Circulating procoagulant microparticles in patients with venous thromboembolism.

Ay C, Freyssinet JM, Sailer T, Vormittag R, Pabinger I. Ay C, et al. Thromb Res. 2009 Mar;123(5):724-6. doi: 10.1016/j.thromres.2008.09.005. Epub 2008 Nov 7. Thromb Res. 2009. PMID: 18995886 No abstract available.

8

Biomarkers and venous thromboembolism.

Pabinger I, Ay C. Pabinger I, et al. Among authors: ay c. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):332-6. doi: 10.1161/ATVBAHA.108.182188. Arterioscler Thromb Vasc Biol. 2009. PMID: 19228607 Review.

9

D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I. Ay C, et al. J Clin Oncol. 2009 Sep 1;27(25):4124-9. doi: 10.1200/JCO.2008.21.7752. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636003

10

High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.

Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C, Zielinski C, Pabinger I. Vormittag R, et al. Among authors: ay c. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2176-81. doi: 10.1161/ATVBAHA.109.190827. Epub 2009 Sep 24. Arterioscler Thromb Vasc Biol. 2009. PMID: 19778945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page